AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABBV New York 2834 http://www.abbvie.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbbVie Inc

5 Experimental New Drugs That Could Be Worth $47 Billion - Jun 20th, 2018 6:07 am
Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks - Jun 20th, 2018 4:01 am
8,000 AbbVie Employees Volunteer Across Five Continents During Fifth-Annual "Week of Possibilities" - Jun 19th, 2018 7:21 am
Wired News – AbbVie Presents New Undetectable Minimal Residual Disease Data from Phase-3 MURANO Trial of Venetoclax with Rituximab at 23rd European Hematology Association Annual Congress - Jun 19th, 2018 5:20 am
3 Great Reasons to Buy Gilead Sciences - Jun 19th, 2018 4:32 am
Bristol-Myers Posts Data on Empliciti, China Approves Opdivo - Jun 18th, 2018 4:23 pm
How U.S. tax reform rewards companies that shift profit to tax havens - Jun 18th, 2018 8:30 am
Today's Research Reports on Trending Tickers: Canopy Growth and AbbVie - Jun 18th, 2018 6:20 am
Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming - Jun 17th, 2018 10:03 am
MARKETS: Here's why stocks are dropping right now - Jun 15th, 2018 8:26 am
Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals - Jun 15th, 2018 7:27 am
3 High-Yield Stocks at Rock-Bottom Prices - Jun 15th, 2018 7:01 am
Better Buy: AbbVie Inc. vs. GlaxoSmithKline plc - Jun 15th, 2018 6:18 am
Analysis: Positioning to Benefit within Canopy Growth, Aurora Cannabis, CannTrust, AbbVie, Cronos Group, and Scotts Miracle-Gro — Research Highlights Growth, Revenue, and Consolidated Results - Jun 15th, 2018 5:35 am
AbbVie Announces New Undetectable Minimal Residual Disease Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of Venetoclax in Combination with Rituximab at 23rd European Hematology Association Annual Congress - Jun 15th, 2018 12:45 am
AbbVie Declares Quarterly Dividend - Jun 14th, 2018 4:52 pm
Humira's Sales Will Decline -- and It's Fantastic News for AbbVie - Jun 13th, 2018 4:01 am
AbbVie Presents Additional Outcomes Data from Three Upadacitinib Phase 3 Studies in Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR 2018) - Jun 12th, 2018 4:38 pm
Abbvie/Roche's Leukemia Drugs Combination Gets FDA Approval - Jun 11th, 2018 8:00 am